Intralink-Spine expands clinical trials to Australia, New Zealand: 4 takeaways

Spinal Tech

Intralink-Spine expanded its clinical studies to Australia and New Zealand through Five Corners, a Sydney, Australia-based contract research organization.

Here are four takeaways.

1. Five Corners will assist Intralink-Spine in their journey to obtain the CE Mark for its Réjuve medical device.

2. The Réjuve is an injectable medical device intended to treat degenerative disc disease, low back pain, scoliosis and more.

3. Intralink-Spine reported positive 12-month results, reflecting Réjuve's ability to reduce or eliminate low back pain and disability.

4. Tom Hedman, PhD, invented the device. He serves as an adjunct associate professor in biomedical engineering at the University of Kentucky in Lexington.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Articles We Think You'll Like

 

Featured Webinars

Featured Whitepapers